Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2.
Lancet. 2022.
PMID: 35691323
Clinical Trial.
[Investigations of drug release containing Cremophor emulsifiers].
István E, Zsuzsanna M, Tünde K, Annamária C, Ildikó C.
István E, et al. Among authors: tunde k.
Acta Pharm Hung. 1998 Nov;68(6):345-9.
Acta Pharm Hung. 1998.
PMID: 9987198
Hungarian.
Item in Clipboard
Cite
Cite